Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fragmin 5,000units/0.2ml inj pre-filled syringes
0208010L0BBABAB
|
Fragmin | Dalteparin sodium | Cardiovascular System | 653 |
|
Fragmin 18,000units/0.72ml inj pre-filled syringes
0208010L0BBAIAI
|
Fragmin | Dalteparin sodium | Cardiovascular System | 330 |
|
Fragmin 15,000units/0.6ml inj pre-filled syringes
0208010L0BBAHAH
|
Fragmin | Dalteparin sodium | Cardiovascular System | 240 |
|
Fragmin 7,500units/0.3ml inj pre-filled syringes
0208010L0BBAKAK
|
Fragmin | Dalteparin sodium | Cardiovascular System | 232 |
|
Fragmin 12,500units/0.5ml inj pre-filled syringes
0208010L0BBAGAG
|
Fragmin | Dalteparin sodium | Cardiovascular System | 175 |
|
Fragmin 10,000units/0.4ml inj pre-filled syringes
0208010L0BBAFAF
|
Fragmin | Dalteparin sodium | Cardiovascular System | 164 |
|
Fragmin 2,500units/0.2ml inj pre-filled syringes
0208010L0BBACAA
|
Fragmin | Dalteparin sodium | Cardiovascular System | 42 |
|
Fragmin 10,000units/1ml inj pre-filled syringes
0208010L0BBAJAJ
|
Fragmin | Dalteparin sodium | Cardiovascular System | 32 |
|
Fragmin 10,000units/1ml solution for injection ampoules
0208010L0BBAAAC
|
Fragmin | Dalteparin sodium | Cardiovascular System | 6 |
|
Fragmin 10,000units/4ml solution for injection ampoules
0208010L0BBADAD
|
Fragmin | Dalteparin sodium | Cardiovascular System | 3 |
|
Fragmin 100,000units/4ml solution for injection vials
0208010L0BBAEAE
|
Fragmin | Dalteparin sodium | Cardiovascular System | 2 |
|
Fragmin 10,000units/4ml solution for injection vials
0208010L0BBAMAM
|
Fragmin | Dalteparin sodium | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.